Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,627 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00434031 | CETRA: Neoadjuvant Caelyx and Trastuzumab in Her-2 Positive Breast Cancer(CETRA) | withdrawn | Phase 2 | 0 | National Cancer Institute, NaplesOTHER | 1 | Jul 30, 2012 | clinicaltrials |
| NCT01647672 | Efficacy and Safety With Albumin-bound Paclitaxel (Abraxane) in the TAC as Neoadjuvant Chemotherapy in Breast Cancer | unknown | Phase 2 / Phase 3 | 60 | Tianjin Medical UniversityOTHER | 1 | Jul 25, 2012 |
| clinicaltrials |
| NCT00006121 | Oxaliplatin in Treating Women With Advanced or Metastatic Breast Cancer That Has Not Responded to Previous Chemotherapy | terminated | Phase 2 | 18 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 7 | Jul 24, 2012 | clinicaltrials |
| NCT00005980 | Comparison of Two Regimens of Liposomal Doxorubicin in Treating Women With Metastatic Breast Cancer | completed | Phase 2 | 116 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 9 | Jul 18, 2012 | clinicaltrials |
| NCT00028873 | R101933 Combined With Chemotherapy in Treating Patients With Metastatic Breast Cancer That Has Not Responded to Previous Chemotherapy | completed | Phase 2 | 35 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 2 | Jul 18, 2012 | clinicaltrials |
| NCT00049660 | Capecitabine Compared With Vinorelbine in Treating Women With Metastatic Breast Cancer | terminated | Phase 2 / Phase 3 | 47 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 5 | Jul 18, 2012 | clinicaltrials |
| NCT00066339 | Gefitinib in Treating Patients With Metastatic Breast Cancer That Has Progressed After Antiestrogen and Nonsteroidal Aromatase Inhibitor Therapy | completed | Phase 2 | 44 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Jul 18, 2012 | clinicaltrials |
| NCT01231802 | Study of Eniluracil + 5-Fluorouracil (5-FU) + Leucovorin Versus Capecitabine in Metastatic Breast Cancer | unknown | Phase 2 | 140 | Adherex Technologies, Inc.INDUSTRY | 2 | Jul 17, 2012 | clinicaltrials |
| NCT01641406 | "Phase II Study of PET Guided Neoadjuvant Chemotherapy (NAC) and Oncotype Guided Hormonal Therapy of Breast Cancer"(NACprotocol) | unknown | Phase 2 | 60 | Auxilio Mutuo Cancer CenterOTHER | 1 | Jul 16, 2012 | clinicaltrials |
| NCT00401427 | HERVIN: Trastuzumab and Vinorelbine in Metastatic Breast Cancer | completed | Phase 2 | 50 | National Cancer Institute, NaplesOTHER | 0 | Jul 13, 2012 | clinicaltrials |
| NCT00788333 | Combination Study of BMS-754807 and Herceptin® in Patients With Advanced or Metastatic Her-2-positive Breast Cancer | completed | Phase 1 / Phase 2 | 40 | Bristol-Myers SquibbINDUSTRY | 5 | Jul 13, 2012 | clinicaltrials |
| NCT00830544 | Study of Neoadjuvant Chemotherapy of Breast Cancer(Neoadjuvant) | unknown | Phase 2 | 54 | Auxilio Mutuo Cancer CenterOTHER | 1 | Jul 13, 2012 | clinicaltrials |
| NCT01005641 | ELBA: Exemestane and Lapatinib in Advanced Breast Cancer(ELBA) | withdrawn | Phase 2 | 0 | National Cancer Institute, NaplesOTHER | 1 | Jul 13, 2012 | clinicaltrials |
| NCT00529984 | A Phase I/II Study With CEA(6D) VRP Vaccine in Patients With Advanced or Metastatic CEA-Expressing Malignancies(CEA(6D)VRP) | completed | Phase 1 / Phase 2 | 28 | AlphaVax, Inc.INDUSTRY | 1 | Jul 12, 2012 | clinicaltrials |
| NCT01611727 | Open-Label,Non-Randomized Trial of Cisplatin Chemotherapy in BRCA1-Positive Metastatic Breast Cancer Patients(Cisplatin) | completed | Phase 2 | 20 | Pomeranian Medical University SzczecinOTHER | 1 | Jul 12, 2012 | clinicaltrials |
| NCT00008437 | MRI-Guided Ultrasound Energy in Treating Patients With Stage I, Stage II, or Stage IIIA Breast Cancer | completed | Phase 2 | — | InSightecINDUSTRY | 2 | Jul 2, 2012 | clinicaltrials |
| NCT00464516 | Preoperative Estetrol in Breast Cancer | completed | Phase 2 | 30 | Pantarhei BioscienceINDUSTRY | 1 | Jul 2, 2012 | clinicaltrials |
| NCT00054470 | Tipifarnib Plus Trastuzumab in Treating Patients With Metastatic Breast Cancer | withdrawn | Phase 2 | 0 | The University of Texas Health Science Center at San AntonioOTHER | 0 | Jun 29, 2012 | clinicaltrials |
| NCT00445406 | Bevacizumab and Doxorubicin Hydrochloride Liposome in Treating Women With Locally Recurrent or Metastatic Breast Cancer | completed | Phase 2 | 43 | Swiss Cancer InstituteOTHER | 1 | Jun 28, 2012 | clinicaltrials |
| NCT00754351 | Docetaxel, Gemcitabine and Bevacizumab for Metastatic Breast Cancer | completed | Phase 2 | 48 | University Hospital of CreteOTHER | 1 | Jun 28, 2012 | clinicaltrials |
| NCT00503750 | Phase II Neoadjuvant Trial of Trastuzumab in Combination With Dose-Dense ABI-007 (Abraxane™) | completed | Phase 2 | 27 | Emory UniversityOTHER | 1 | Jun 25, 2012 | clinicaltrials |
| NCT01042938 | Curcumin for the Prevention of Radiation-induced Dermatitis in Breast Cancer Patients | completed | Phase 2 | 35 | University of RochesterOTHER | 1 | Jun 25, 2012 | clinicaltrials |
| NCT00784849 | Feasibility of One-Step Sentinel Lymph Node (SLN) Biopsy With Radiolabeled Methylene Blue (IND 70,627) | completed | Phase 2 | 62 | Louisiana State University Health Sciences Center in New OrleansOTHER | 1 | Jun 20, 2012 | clinicaltrials |
| NCT00004172 | Chemotherapy, Filgrastim, and Stem Cell Transplantation With Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer | completed | Phase 2 | — | Northwestern UniversityOTHER | 1 | Jun 12, 2012 | clinicaltrials |
| NCT00057993 | Trastuzumab and Exemestane in Treating Postmenopausal Women With Metastatic or Locally Advanced Breast Cancer | withdrawn | Phase 2 | 0 | Northwestern UniversityOTHER | 0 | Jun 11, 2012 | clinicaltrials |
| NCT00131924 | High-Dose Esterified Estrogens in Treating Postmenopausal Women With Metastatic Breast Cancer That Has Failed Previous Hormone Therapy | terminated | Phase 2 | 1 | Northwestern UniversityOTHER | 1 | Jun 11, 2012 | clinicaltrials |
| NCT01288092 | BEZ235 Trial in Patients With HER2-(Human Epidermal Growth Factor Receptor 2 Negative) /HR+ (Hormonal Receptor Positive) Metastatic Breast Cancer | withdrawn | Phase 2 | 0 | Novartis PharmaceuticalsINDUSTRY | 0 | Jun 7, 2012 | clinicaltrials |
| NCT00004175 | Docetaxel, Doxorubicin, and Cyclophosphamide in Treating Women With Stage III Breast Cancer | completed | Phase 2 | — | Northwestern UniversityOTHER | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00004182 | Irinotecan in Treating Patients With Metastatic or Recurrent Breast Cancer | completed | Phase 2 | — | Northwestern UniversityOTHER | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00005608 | Fluorouracil-Uracil and Leucovorin in Treating Women With Metastatic Breast Cancer | terminated | Phase 2 | — | Northwestern UniversityOTHER | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00006225 | Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer | completed | Phase 1 / Phase 2 | — | Northwestern UniversityOTHER | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00479856 | Lapatinib In Combination With Chemotherapy In Subjects With Relapsed Breast Cancer | terminated | Phase 2 | 9 | GlaxoSmithKlineINDUSTRY | 1 | Jun 5, 2012 | clinicaltrials |
| NCT01609127 | Tesetaxel Every 3 Weeks vs Weekly vs Capecitabine as 1st-line Therapy for Locally Advanced or Metastatic Breast Cancer | unknown | Phase 2 | 213 | Genta IncorporatedINDUSTRY | 1 | Jun 1, 2012 | clinicaltrials |
| NCT00935558 | Dendritic Cell Based Therapy for Breast Cancer Patients | withdrawn | Phase 2 | 0 | Inge Marie SvaneOTHER | 1 | May 31, 2012 | clinicaltrials |
| NCT00135018 | Study on the Neoadjuvant Use of Chemotherapy and Celecoxib Therapy in Patients With Invasive Breast Cancer | completed | Phase 2 | — | Organisation for Oncology and Translational ResearchOTHER | 1 | May 24, 2012 | clinicaltrials |
| NCT00237627 | Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 107 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | May 18, 2012 | clinicaltrials |
| NCT00004046 | Chemotherapy in Treating Women With Metastatic Breast Cancer | completed | Phase 2 | — | Daiichi SankyoINDUSTRY | 1 | May 16, 2012 | clinicaltrials |
| NCT00286819 | Dose Density FU 75 and FU 90 as Adjuvant Therapy for Early Breast Cancer | completed | Phase 2 | 50 | Central European Cooperative Oncology GroupOTHER | 4 | May 16, 2012 | clinicaltrials |
| NCT00003902 | Capecitabine and Vinorelbine in Treating Older Women Who Have Metastatic Breast Cancer With or Without Bone Involvement | completed | Phase 1 / Phase 2 | 110 | Swiss Cancer InstituteOTHER | 1 | May 15, 2012 | clinicaltrials |
| NCT00031876 | Capecitabine and Paclitaxel in Treating Patients With Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 34 | Swiss Cancer InstituteOTHER | 1 | May 15, 2012 | clinicaltrials |
| NCT00251472 | A Phase II Trial of Abraxane™ Given Weekly as a Single Agent in First-line Treatment of Metastatic Breast Cancer | completed | Phase 2 | 72 | Veeda OncologyOTHER | 1 | May 11, 2012 | clinicaltrials |
| NCT00607438 | A Phase II Study Of Abraxane and Nexavar in the First-Line Treatment of Locally Advanced or Metastatic Breast Cancer | terminated | Phase 2 | 16 | Veeda OncologyOTHER | 1 | May 11, 2012 | clinicaltrials |
| NCT00768859 | Trastuzumab in a Neo-adjuvant Regimen for HER2+ Breast Cancer - the TRAIN Study(TRAIN) | completed | Phase 2 | 111 | The Netherlands Cancer InstituteOTHER | 1 | May 11, 2012 | clinicaltrials |
| NCT00083278 | Study of MDX-010 in Stage IV Breast Cancer | completed | Phase 2 | 33 | Bristol-Myers SquibbINDUSTRY | 1 | Apr 27, 2012 | clinicaltrials |
| NCT00343512 | Docetaxel Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer | terminated | Phase 2 | 34 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Apr 27, 2012 | clinicaltrials |
| NCT00467012 | Phase Ⅱ Clinical Study of R435 (Bevacizumab) in Combination With Paclitaxel in Patients With Inoperable Metastatic Breast Cancer | completed | Phase 2 | 122 | Chugai PharmaceuticalINDUSTRY | 1 | Apr 26, 2012 | clinicaltrials |
| NCT00816244 | Study of Statin as Neo-Adjuvant Therapy in Postmenopausal Breast Cancer | completed | Phase 2 | 50 | Lund University HospitalOTHER | 1 | Apr 13, 2012 | clinicaltrials |
| NCT01208480 | Bevacizumab, Docetaxel, and Carboplatin in Treating Women With Stage II or Stage III Breast Cancer | completed | Phase 2 | 45 | Severance HospitalOTHER | 1 | Apr 10, 2012 | clinicaltrials |
| NCT00265655 | Satraplatin for Patients With Metastatic Breast Cancer (MBC) | completed | Phase 2 | 40 | AgennixINDUSTRY | 1 | Mar 28, 2012 | clinicaltrials |
| NCT01048528 | Health SMART (Stress Management and Relaxation Training) | completed | Phase 2 | 33 | Fred Hutchinson Cancer CenterOTHER | 1 | Mar 27, 2012 | clinicaltrials |
Data updated 24 days agoSource updated Jul 30, 2012source: clinicaltrials